4.1.1.2	AnODC, Decarboxylase, oxalate, FvOXDC, ODC, ODC B, ODC C, ODC E, ODC F, odc2, oxalate carboxy-lyase, oxalate-decarboxylase, OXD, OXDC, OxDcase, TOXDC, YoaN, YvrK	-	-, 650168, 651021, 651590, 651662, 652089, 652196, 677825, 678138, 678229, 681596, 687082, 690331, 691955, 692203, 692903, 693597, 694237, 701766, 702319, 704104, 705343, 713879, 714726, 715086, 716726, 726979, 727124, 727612, 727697, 727707, 728195, 728346, 728524, 747145, 747434, 747620, 747628, 747828, 748244, 748313, 748708, 748822, 748902	
4.1.1.2	additional information	belongs to the cupin superfamily, bicupin	-, 650168, 651662, 652196	
4.1.1.2	OxDc-CLEC	commercial preparation	690331	
4.1.1.2	additional information	enzyme belongs to the cupin superfamily, bicupin	-, 652532	
4.1.1.2	OxdD	formerly YoaN	651732	
4.1.1.2	OXDC	formerly YvrK	-, 652532	
4.1.1.2	additional information	member of the cupin superfamily	-, 651590	
4.1.1.2	oxazyme	oxazyme (OC4) is an orally administered formulation that has as an active component a recombinant mutant form of Bacillus subtilis oxalate decarboxylase (OxDC) enzyme C383S	704104	
4.1.1.2	AtuOXDC	putative recombinant enzyme, contains N- and C-cupin domains of OXDC	-, 693597	
4.1.1.2	pBy	recombinant gene name	-, 747434